Alveolus Bio, Inc.
Birmingham, AL
- UEI
- CZDCV9W7CRC4
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1500 1st Ave N H102, Birmingham, AL 35203, USA
- Website
- alveolusbio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Leveraging live biotherapeutics for the treatment of chronic rhinosinusitis - project summary chronic rhinosinusitis… | National Institute of Allergy and Infectious Diseases | $301,768 | |
| An inhaled microbiome-targeted biotherapeutic for treatment of copd - project summary - resbiotic INC. Is developing its… | National Heart Lung and Blood Institute | $5,483,512 |
Quick answers
What is Alveolus Bio, Inc.'s UEI?
Alveolus Bio, Inc.'s Unique Entity ID (UEI) in SAM.gov is CZDCV9W7CRC4.
Where is Alveolus Bio, Inc. located?
Alveolus Bio, Inc.'s physical address in SAM.gov is 1500 1st Ave N H102, Birmingham, AL 35203, USA.
Is Alveolus Bio, Inc. registered in SAM.gov?
Yes. Alveolus Bio, Inc.'s SAM.gov registration is active through February 6, 2027.
What is Alveolus Bio, Inc.'s most recent federal award?
Alveolus Bio, Inc.'s most recent federal grant award is Leveraging live biotherapeutics for the treatment of chronic rhinosinusitis - project summary chronic rhinosinusitis… (R43AI197548), from National Institute of Allergy and Infectious Diseases, on September 1, 2026.
On GovTribe
See Alveolus Bio, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors